DRI Healthcare Trust (DHT.UN) Competitors C$16.95 +0.15 (+0.89%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock DHT.UN vs. BHC, CRON, THCX, TLRY, and GUDShould you buy DRI Healthcare Trust stock or one of its competitors? MarketBeat compares DRI Healthcare Trust with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DRI Healthcare Trust include Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Tilray Brands (TLRY), and Knight Therapeutics (GUD). These companies are all part of the "drug manufacturers - specialty & generic" industry. DHT.UN vs. BHCDHT.UN vs. CRONDHT.UN vs. THCXDHT.UN vs. TLRYDHT.UN vs. GUDHow does DRI Healthcare Trust compare to Bausch Health Companies?Bausch Health Companies (TSE:BHC) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings. Which has more risk & volatility, BHC or DHT.UN? Bausch Health Companies has a beta of 0.631102, meaning that its stock price is 37% less volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.347429, meaning that its stock price is 65% less volatile than the broader market. Do analysts prefer BHC or DHT.UN? DRI Healthcare Trust has a consensus price target of C$25.50, suggesting a potential upside of 50.44%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to BHC or DHT.UN? In the previous week, Bausch Health Companies had 9 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 12 mentions for Bausch Health Companies and 3 mentions for DRI Healthcare Trust. DRI Healthcare Trust's average media sentiment score of 1.00 beat Bausch Health Companies' score of -0.25 indicating that DRI Healthcare Trust is being referred to more favorably in the news media. Company Overall Sentiment Bausch Health Companies Neutral DRI Healthcare Trust Positive Which has stronger valuation & earnings, BHC or DHT.UN? DRI Healthcare Trust has lower revenue, but higher earnings than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health CompaniesC$10.53B0.27-C$125.65M-C$3.24N/ADRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A Do insiders and institutionals have more ownership in BHC or DHT.UN? 10.0% of Bausch Health Companies shares are held by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is BHC or DHT.UN more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat DRI Healthcare Trust's return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-13.54% 120.43% 4.16% DRI Healthcare Trust 5.02%2.06%4.22% SummaryDRI Healthcare Trust beats Bausch Health Companies on 9 of the 16 factors compared between the two stocks.How does DRI Healthcare Trust compare to Cronos Group?DRI Healthcare Trust (TSE:DHT.UN) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation. Is DHT.UN or CRON more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of -1.29%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Cronos Group -1.29%-0.19%-3.73% Which has higher earnings & valuation, DHT.UN or CRON? DRI Healthcare Trust has higher revenue and earnings than Cronos Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/ACronos GroupC$159.54M8.92-C$32.78MN/AN/A Do analysts rate DHT.UN or CRON? DRI Healthcare Trust currently has a consensus target price of C$25.50, indicating a potential upside of 50.44%. Cronos Group has a consensus target price of C$4.75, indicating a potential upside of 24.67%. Given DRI Healthcare Trust's higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer DHT.UN or CRON? In the previous week, DRI Healthcare Trust had 3 more articles in the media than Cronos Group. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.00 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media. Company Overall Sentiment DRI Healthcare Trust Positive Cronos Group Neutral Which has more risk & volatility, DHT.UN or CRON? DRI Healthcare Trust has a beta of 0.347429, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.11805, suggesting that its stock price is 12% more volatile than the broader market. Do insiders & institutionals believe in DHT.UN or CRON? 0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryDRI Healthcare Trust beats Cronos Group on 9 of the 13 factors compared between the two stocks.How does DRI Healthcare Trust compare to Hydropothecary?Hydropothecary (CVE:THCX) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends. Is THCX or DHT.UN more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.Company Net Margins Return on Equity Return on Assets HydropothecaryN/A N/A N/A DRI Healthcare Trust 5.02%2.06%4.22% Does the media refer more to THCX or DHT.UN? In the previous week, DRI Healthcare Trust had 3 more articles in the media than Hydropothecary. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Hydropothecary. DRI Healthcare Trust's average media sentiment score of 1.00 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media. Company Overall Sentiment Hydropothecary Neutral DRI Healthcare Trust Positive Do insiders & institutionals have more ownership in THCX or DHT.UN? 0.6% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend THCX or DHT.UN? DRI Healthcare Trust has a consensus target price of C$25.50, suggesting a potential upside of 50.44%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hydropothecary 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, THCX or DHT.UN? DRI Healthcare Trust has higher revenue and earnings than Hydropothecary. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHydropothecaryN/AN/AN/AN/AN/ADRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/A SummaryDRI Healthcare Trust beats Hydropothecary on 11 of the 11 factors compared between the two stocks.How does DRI Healthcare Trust compare to Tilray Brands?DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations. Does the media refer more to DHT.UN or TLRY? In the previous week, DRI Healthcare Trust had 3 more articles in the media than Tilray Brands. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Tilray Brands. DRI Healthcare Trust's average media sentiment score of 1.00 beat Tilray Brands' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media. Company Overall Sentiment DRI Healthcare Trust Positive Tilray Brands Neutral Do institutionals & insiders hold more shares of DHT.UN or TLRY? 0.6% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by insiders. Comparatively, 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, DHT.UN or TLRY? DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/ATilray BrandsC$858.28M1.05-C$183.24M-C$14.63N/A Which has more risk & volatility, DHT.UN or TLRY? DRI Healthcare Trust has a beta of 0.347429, meaning that its share price is 65% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.243166, meaning that its share price is 224% more volatile than the broader market. Do analysts rate DHT.UN or TLRY? DRI Healthcare Trust currently has a consensus target price of C$25.50, suggesting a potential upside of 50.44%. Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 77.33%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than DRI Healthcare Trust.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is DHT.UN or TLRY more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -158.75%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Tilray Brands -158.75%-88.06%-1.41% SummaryDRI Healthcare Trust beats Tilray Brands on 10 of the 16 factors compared between the two stocks.How does DRI Healthcare Trust compare to Knight Therapeutics?DRI Healthcare Trust (TSE:DHT.UN) and Knight Therapeutics (TSE:GUD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership. Do analysts prefer DHT.UN or GUD? DRI Healthcare Trust currently has a consensus price target of C$25.50, suggesting a potential upside of 50.44%. Knight Therapeutics has a consensus price target of C$9.50, suggesting a potential upside of 13.64%. Given DRI Healthcare Trust's higher probable upside, research analysts clearly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Knight Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DHT.UN or GUD more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of 1.10%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Knight Therapeutics 1.10%0.73%0.51% Does the media prefer DHT.UN or GUD? In the previous week, DRI Healthcare Trust had 3 more articles in the media than Knight Therapeutics. MarketBeat recorded 3 mentions for DRI Healthcare Trust and 0 mentions for Knight Therapeutics. DRI Healthcare Trust's average media sentiment score of 1.00 beat Knight Therapeutics' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media. Company Overall Sentiment DRI Healthcare Trust Positive Knight Therapeutics Neutral Do insiders & institutionals hold more shares of DHT.UN or GUD? 0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 23.2% of Knight Therapeutics shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 45.6% of Knight Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation & earnings, DHT.UN or GUD? DRI Healthcare Trust has higher earnings, but lower revenue than Knight Therapeutics. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$163.77M5.69C$9.73M-C$0.90N/AKnight TherapeuticsC$510.45M1.61-C$30.73MC$0.06139.33 Which has more volatility and risk, DHT.UN or GUD? DRI Healthcare Trust has a beta of 0.347429, suggesting that its share price is 65% less volatile than the broader market. Comparatively, Knight Therapeutics has a beta of -0.214451, suggesting that its share price is 121% less volatile than the broader market. SummaryDRI Healthcare Trust beats Knight Therapeutics on 10 of the 15 factors compared between the two stocks. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition ExportMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$932.52MC$2.22BC$6.45BC$12.16BDividend Yield3.45%2.95%2.76%6.20%P/E Ratio-18.835.1621.2237.64Price / Sales5.691,770.59553.9211.68Price / CashN/A10.1843.4982.29Price / Book1.8210.6110.374.50Net IncomeC$9.73MC$20.70BC$3.57BC$299.09M7 Day Performance5.02%5.88%6.01%1.38%1 Month Performance2.67%3.71%3.52%1.46%1 Year Performance34.10%23.05%34.13%55.45% DRI Healthcare Trust Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare Trust2.6745 of 5 starsC$16.95+0.9%C$25.50+50.4%+32.9%C$932.52MC$163.77MN/AN/APositive NewsBHCBausch Health Companies0.7298 of 5 starsC$7.55+0.3%N/A+23.4%C$2.82BC$10.53BN/A19,900CRONCronos Group2.4406 of 5 starsC$3.77-0.5%C$4.75+26.0%+35.1%C$1.41BC$159.54MN/A450THCXHydropothecaryN/AC$5.30+6.6%N/A+0.0%C$949.11MN/AN/AN/AHigh Trading VolumeTLRYTilray Brands1.2797 of 5 starsC$7.33-2.9%C$13.30+81.4%+22.2%C$876.70MC$858.28MN/A2,650 Related Companies and Tools Related Companies Bausch Health Companies Competitors Cronos Group Competitors Hydropothecary Competitors Tilray Brands Competitors Knight Therapeutics Competitors Canopy Growth Competitors Cipher Pharmaceuticals Competitors SugarBud Craft Growers Competitors Aurora Cannabis Competitors Supreme Cannabis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:DHT.UN) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
